COMP <GO>
BYSI vs AYTU // EV/EBITDA & P/E VALUATION
BeyondSpring Inc. (NASDAQ) VS. Aytu BioPharma Inc. (NASDAQ) • 15-METRIC TALLY: BYSI 1
— AYTU 2
■ METRIC PARITY
LAST: $0.52 (-1.49%) • MKT CAP: $21.2M
valuation
—
LAST: $1.98 (+0.51%) • MKT CAP: $21.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BYSI VS. AYTU)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BYSI | AYTU | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 69.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -10.06% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -11.80% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -20.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 1.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | AYTU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 42.0 | +12.09 | BYSI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.2M | $21.5M | -$272.4K | AYTU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BYSI REV | AYTU REV | BYSI GROSS % | AYTU GROSS % | BYSI FCF | AYTU FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $66.4M | — | 69.0% | -$19.8M | -$2.2M |
| FY 2024 | $0 | $65.2M | — | 75.3% | -$16.7M | -$1.7M |
| FY 2023 | $0 | $107.4M | — | — | -$16.5M | -$5.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BYSI // BETA —
AYTU // BETA —